In a multicentre pooled analysis of 531 patients with metastatic NSCLC treated with Nivolumab as a second line therapy, 33.0% (173 patients) developed irAEs and had a significantly longer OS (14.9 versus 7.4 months
31 P NMR (162 MHz, CDCl 3 ) 24.44
With the use of PCCl3 thyroid cells, it has been documented that iodide, used in concentrations corresponding to those causing WolffChaikoff effect (10 3 M to 10 6 M), increased ROS production in thyroid follicular cells
The effects become visible within four weeks, and the significant effects may need a maximum of three months
Sources: Hsieh MJ, Liu HT, Wang CN, et al
The addition of semaglutide to this already high-risk group showed further b12 decline, but whether this represents a medication effect, dietary changes from additional appetite suppression, or natural progression of post-surgical deficiency remains unclear